Holen Sie sich die Stockscreener-App
4.88
55.41%
1.74
Schlusskurs vom Vortag:
$3.14
Offen:
$4.29
24-Stunden-Volumen:
33.11M
Relative Volume:
16.13
Marktkapitalisierung:
$4.81M
Einnahmen:
$31,800
Nettoeinkommen (Verlust:
$-37.83M
KGV:
-6.8732
EPS:
-0.71
Netto-Cashflow:
$-30.64M
1W Leistung:
+192.22%
1M Leistung:
+373.79%
6M Leistung:
-30.44%
1J Leistung:
-92.18%
1-Tages-Spanne:
$3.53
$5.88
1-Wochen-Bereich:
$1.62
$5.88
52-Wochen-Spanne:
$0.85
$124.80
Eyenovia Inc Stock (EYEN) Company Profile
Firmenname
Eyenovia Inc
Sektor
Branche
Telefon
813-766-9539
Adresse
295 MADISON AVENUE,, NEW YORK, NY
Vergleichen Sie EYEN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EYEN
Eyenovia Inc
|
4.88 | 4.81M | 31,800 | -37.83M | -30.64M | -0.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
450.50 | 113.52B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
493.22 | 52.93B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
300.83 | 39.71B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
585.93 | 35.00B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
255.86 | 26.57B | 3.81B | -644.79M | -669.77M | -6.24 |
Eyenovia Inc Stock (EYEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-18 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2021-03-01 | Eingeleitet | Northland Capital | Outperform |
| 2020-02-03 | Herabstufung | Oppenheimer | Outperform → Perform |
Eyenovia Inc Aktie (EYEN) Neueste Nachrichten
Eyenovia (EYEN) Stock Skyrockets Over 23% on Nasdaq, Showing Explosive Short-Term Rally - Daily Chhattisgarh News
Eyenovia (EYEN) Stock Explodes Following Amended Loan Agreement Terms: What's Going On? - Benzinga
Eyenovia On May 30, Enters Third Amendment To Loan And Security AgreementSEC Filing - marketscreener.com
eyenovia amends loan agreement, limits stock conversion option - Investing.com
Eyenovia Amends Loan Agreement with Avenue Capital - TipRanks
Innovations in Imaging, such as AI-Enhanced Retinal & Fundus Camera Systems are Booming Along with Revenue Opportunities - GlobeNewswire Inc.
Eyenovia provides update on potential merger and Optejet development - MSN
Eyenovia Provides Updates on Potential Merger with Betaliq and D - GuruFocus
Eyenovia Advances Merger Talks With Betaliq And Targets FDA Filing For Optejet Device - Nasdaq
Eyenovia (EYEN) Shares Explode On Betaliq Merger Progress, Strong Q1 Financials - Benzinga
Eyenovia Reports Q1 2025 Progress and Financials - TipRanks
Eyenovia advances on merger talks, cuts cash burn, eyes September FDA filing By Investing.com - Investing.com South Africa
Eyenovia advances on merger talks, cuts cash burn, eyes September FDA filing - Investing.com Australia
Eyenovia Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Eyenovia (EYEN) Pursues Merger with Betaliq and Advances Optejet Device | EYEN Stock News - GuruFocus
Eyenovia Provides Updates on Potential Merger with Betaliq and Development of the Optejet User Filled Device (UFD), and Reports First Quarter 2025 Financial Results | EYEN Stock News - GuruFocus
Eyenovia Provides Updates on Potential Merger with Betaliq and Development of the Optejet User Filled Device (UFD), and Reports First Quarter 2025 Financial Results - The Manila Times
Eyenovia, Inc. Provides Merger Update with Betaliq and Financial Results for Q1 2025 - Nasdaq
Eyenovia Provides Updates On Potential Merger With Betaliq And Development Of The Optejet User Filled Device (Ufd), And Reports First Quarter 2025 Financial Results - marketscreener.com
Eyenovia Provides Updates on Potential Merger with Betaliq - GlobeNewswire
Eyenovia Slashes Cash Burn 70% While Racing Toward Major FDA Filing and Merger Deal - Stock Titan
Public market insider buying at TC Energy (TRP) - The Globe and Mail
Eyenovia Delays Q1 2025 10-Q Filing - TipRanks
3 Monster Stocks in the Making - The Globe and Mail
‘Buy MSFT, AMZN, GOOGL, and PLTR Stocks,’ Says Wedbush - The Globe and Mail
My 3 Favorite Stocks to Buy Right Now - The Globe and Mail
Eyenovia Faces Nasdaq Delisting Over Equity Shortfall By Investing.com - Investing.com India
Eyenovia Faces Nasdaq Delisting Over Equity Shortfall - Investing.com
EYENEyenovia Inc Latest Stock News & Market Updates - Stock Titan
Where Will Walmart Stock Be in 1 Year? - The Globe and Mail
Press Release Distribution & PR Platform - ACCESS Newswire
Eyenovia Inc reports results for the quarter ended December 31Earnings Summary - TradingView
EYENOVIA, INC. SEC 10-K Report - TradingView
Eyenovia Inc expected to post a loss of $7.20 a shareEarnings Preview - TradingView
Eyenovia (EYEN) Advances with Optejet User Filled Device Development | EYEN Stock News - GuruFocus
Eyenovia Provides Development Update on Optejet User Filled Devi - GuruFocus
Eyenovia nears regulatory submission for Optejet UFD device By Investing.com - Investing.com South Africa
Eyenovia Provides Development Update on Optejet User Filled Device (UFD) - The Manila Times
Eyenovia nears regulatory submission for Optejet UFD device - Investing.com
Eyenovia provides development update on Optejet UFD - TipRanks
Revolutionary Eye Drug Device Passes Critical Tests: Eyenovia's Game-Changing Innovation - Stock Titan
Mydriasis Market Predicted to See Upsurge Through 2034, - openPR.com
Mydriasis Market Predicted to See Upsurge Through 2034, Highlights DelveInsight | Viatris/Ocuphire Pharma, Eyenovia, Rayner Surgical/Omeros, Eyenovia Inc., Taejoon Pharma - Barchart.com
Eyenovia Delays Yearly Report Filing - TipRanks
Deal Watch: Eyenovia Looks At New Direction In Proposed Merger With Betaliq - insights.citeline.com
Eyenovia’s Strategic Position and Uncertain Prospects: Hold Rating Amid Merger and Growth Challenges - TipRanks
Eyenovia falls on plans to seek reverse merger - MSN
Eyenovia Enters Into Non-Binding Letter of Intent to Effect Reverse Merger With Betaliq - VisionMonday.com
Eyenovia And Betaliq Announce Potential Reverse Merger - Nasdaq
Eyenovia Shares Drop 14% Amid Betaliq Merger Talks - Yahoo
Finanzdaten der Eyenovia Inc-Aktie (EYEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Eyenovia Inc-Aktie (EYEN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Rowe Michael M | Chief Executive Officer |
Aug 26 '24 |
Buy |
0.57 |
50,000 |
28,500 |
82,927 |
| Grant Stuart M. | 10% Owner |
Jul 02 '24 |
Buy |
0.66 |
1,515,151 |
1,000,000 |
10,914,153 |
1.21%
1.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):